![](https://i0.wp.com/shacklemedia.com/wp-content/uploads/2023/12/pfizers-weight-loss-drug-wont-enter-a-phase-3-trial-the-stock-drops.jpg?w=640&ssl=1)
Pfizer stock was falling Friday after the biopharmaceutical company announced that it will not be moving forward with a Phase 3 trial of its weight loss candidate.
Continue reading this article with a Barron’s subscription.
Source: finance.yahoo.com
Related posts:
Saudi Arabia may make surprise oil cuts, sending prices soaring and the futures market into backward...
3 Millionaire-Maker Technology Stocks
3 REITs That Should Survive Dividend Cuts In A Bad Recession
Walmart heirs to candy conglomerates: These are the 25 richest families in the US
It’s Time to Bargain Hunt. 27 Picks to Beat the Stock Market From Barron’s Roundtable Experts.